Palliative care intervention for older adults with advanced cancer in skilled nursing facilities
Official title: Improving Person-Centered Outcomes for Older Adults With Cancer Discharged to Skilled Nursing Facilities and Their Family Caregivers
Run by University of Colorado, Denver · NCT06616298 · Data updated 2026-11-12
This study is testing a new palliative care program for older adults with advanced cancer in nursing facilities to see if it helps them and their caregivers make better medical decisions compared to regular care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 98 Years |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | University of Colorado, Denver Academic / other |
| Locations | 1 site (Aurora, Colorado) |
| Status | Recruiting |
| Started | February 24, 2025 |
| Main results expected | August 24, 2027 |
| Study ends | August 1, 2028 |
| Registry record updated | May 5, 2026 |
| Trial ID | NCT06616298 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include English-speaking adults aged 18-98 with stage II-IV solid tumors who are being discharged to a skilled nursing facility in Colorado.
✕Probably not a fit
Patients discharging with hospice care or those without a legal surrogate decision-maker may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate the feasibility of delivering a palliative care intervention called ALIGN to older adults with advanced cancer who are transitioning from acute care hospitals to skilled nursing facilities. Participants will engage in virtual visits with a palliative care social worker every 1-2 weeks during their stay and up to 45 days post-discharge. The study will also focus on preparing caregivers to make informed medical decisions for their loved ones. Researchers will compare the outcomes of the ALIGN intervention with standard care practices.
Why it matters
Potential benefit: If successful, this intervention could enhance the quality of palliative care for older adults with advanced cancer and support their caregivers in decision-making.
How similar studies have gone: While similar palliative care interventions have shown promise, this specific approach in skilled nursing facilities is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Patients Inclusion Criteria: 1. Adults between 18-98 years 2. Stage I-IV solid tumors 3. Discharging from an acute care hospital to a SNF in Colorado 4. English speaking 5. Receiving or establishing care at the University of Colorado Cancer Center 6. If a patient lacks capacity, a legal surrogate decision-maker will be approached to provide proxy consent. 7. Must have access to the technology needed to complete consenting visit and subsequent intervention visits. This includes internet access through a computer, tablet, or smartphone OR cellular service with adequate allowance of cellular minutes to allow virtual visits. 8. Must have an email address or caregiver with an email address to facilitate communication during the trial Exclusion Criteria: 1. Discharging with hospice care 2. Age less than 18 3. Lacking capacity without a legal surrogate decision maker or proxy. 4. Limited English proficiency 5. Hospitalized for a planned admission or procedure 6. Have any pschological or physical symptom, medication or other relevant finding prior to randomization, based on the clinical judgement of the PI or relevant clinical study staff that would make a participant unsuitable for the study Caregivers Inclusion Criteria: 1. Patient-selected 2. Age ≥ 18 3. English speaking 4. Able to complete baseline measures. Exclusion Criteria: 1. Discharging with hospice care 2. Age ≤ 18 3. Caregivers with limited English proficiency will be excluded as ALIGN intervention content and documents have only been validated in an English-speaking population. 4. Have any pschological or physical symptom, medication or other relevant finding prior to randomization, based on the clinical judgement of the PI or relevant clinical study staff that would make a participant unsuitable for the study SNF Staff Inclusion Criteria: 1\. Working at a SNF that cared for a patient who received the ALIGN intervention Exclusion Criteria: 1\. Not employed by a community SNF where patients were discharged to during the pilot trial PCSW Inclusion Criteria: 1\. PCSWs who conducted the ALIGN intervention and consent to an interview
Where it's running
-
University of Colorado Anschutz Medical Campus
Aurora, Colorado, United States Recruiting
Study contacts
- Principal investigator: Sarguni Singh, MD — University of Colorado, Denver
- Study coordinator: Sarguni Singh, MD
- Email: sarguni.singh@cuanschutz.edu
- Phone: 503.703.0797
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Concise coaching to guide decisions for advanced cancer patients considering palliative procedures
A coaching program delivered by lay providers will test whether it helps adults with advanced cancer make better, patient-aligned decisions about palliative surgeries or similar interventions.
-
Primary Palliative Care: A Feasibility Project for Family Health Units
This feasibility trial tests a GP training program plus a structured 12-week palliative-care visit plan to see if it can be carried out in primary care for adults with advanced illness.
-
Virtual Group Resilient Living for Advanced Cancer
A group-based online program tests whether seven weekly sessions can reduce anxiety and fatigue and improve quality of life for adults with advanced cancer.
-
IV contrast-enhanced CBCT with HyperSight for image guidance in advanced cancer radiotherapy
This study tests whether giving IV contrast during cone-beam CT helps doctors see the tumor better during radiotherapy in people with advanced cancer.
-
Single-session celiac plexus SBRT using a simulation-free adaptive workflow for cancer-related pain
A pilot test to see if a one-day, simulation-free adaptive radiotherapy process can safely deliver celiac plexus SBRT to adults with advanced pancreatic or other cancers.
-
UI-102 in advanced cancers (phase 1/2) first-in-human
A first-in-human study tests UI-102, given to adults with advanced solid tumors to see if it is safe and shows signs of benefit.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.